Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
Nano Letters|August 21, 2008
Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivoKevin C Weng, Charles O Noble, Brigitte Papahadjopoulos-Sternberg, et al.Cancer Research|April 3, 2004
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imagingRyuta Saito, John R Bringas, Tracy R McKnight, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryJohn W Park, Keelung Hong, Dmitri B Kirpotin, et al.Plos One|October 27, 2015
A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex ImmunoassayMark Jesus M Magbanua, Michael Pugia, Jin Sun Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancerA Jo Chien, Pamela N Munster, Michelle E Melisko, et al.Brain Research. Brain Research Protocols|September 27, 2005
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imagingMichal T Krauze, Tracy R Mcknight, Yoji Yamashita, et al.Nanomedicine (London, England)|February 6, 2014
Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumorsCharles O Noble, Michal T Krauze, Daryl C Drummond, et al.Breast Cancer Research and Treatment|December 27, 2011
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerHope S Rugo, A Jo Chien, Sandra X Franco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neuPrema P Peethambaram, Michelle E Melisko, Kristine J Rinn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without BevacizumabMark Jesus M Magbanua, Oleksandr Savenkov, Erik J Asmus, et al.Pageof 11